Adamax vs Dihexa
A side-by-side research comparison of Adamax and Dihexa across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Adamax | Dihexa |
|---|---|---|
| Full name | Adamax (Semax Analog Nootropic Peptide) | Dihexa (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide) |
| Category | Cognitive & Nootropic | Cognitive & Nootropic |
| Status | Research peptide | Research compound |
| Mechanism | As an ACTH/melanocortin-derived peptide analog, it is proposed to elevate BDNF and other neurotrophic factors, modulate the dopaminergic and serotonergic systems, and provide neuroprotection, similar to but reportedly more potent and longer-acting than Semax. | Allosteric potentiator of HGF/c-Met signaling driving synaptogenesis, dendritic spine formation, and neuronal survival in hippocampal circuits. |
| Molecular weight | ~ (short peptide) | 507.6 Da |
| Half-life | Short (extended vs Semax) | 6-12 hours |
| Bioavailability | Intranasal or subcutaneous | Moderate (oral/SubQ) |
| Typical dose | Low microgram-to-milligram range (research) | 10-20 mg (oral) or 2-5 mg (SubQ) |
| Frequency | 1-2x daily | Daily |
| Route | Intranasal or subcutaneous | Oral or Subcutaneous |
Adamax reported benefits
- Cognitive enhancement and focus
- Memory support
- Neuroprotection
- BDNF elevation (proposed)
- Mood support
Dihexa reported benefits
- Dramatic synaptogenesis
- Memory improvement
- Cognitive restoration potential
- Dendritic spine growth
- HGF/c-Met activation
Related comparisons
Research and educational reference only. Not medical advice.